Ngā hua rapu - Shin‐ichiro Imai
- E whakaatu ana i te 1 - 20 hua o te 54
- Haere ki te Whārangi Whai Ake
-
1
Therapeutic potential of SIRT1 and NAMPT-mediated NAD biosynthesis in type 2 diabetes mā Shin‐ichiro Imai
I whakaputaina 2009Revisão -
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
NAD+ and sirtuins in aging and disease mā Shin‐ichiro Imai, Leonard Guarente
I whakaputaina 2014Revisão -
11
-
12
-
13
Systemic regulation of mammalian ageing and longevity by brain sirtuins mā Akiko Satoh, Shin‐ichiro Imai
I whakaputaina 2014Revisão -
14
It takes two to tango: NAD+ and sirtuins in aging/longevity control mā Shin‐ichiro Imai, Leonard Guarente
I whakaputaina 2016Revisão -
15
NAD+ biosynthesis, aging, and disease mā Sean Johnson, Shin‐ichiro Imai
I whakaputaina 2018Pré-impressão -
16
-
17
The dynamic regulation of NAD metabolism in mitochondria mā Liana R. Stein, Shin‐ichiro Imai
I whakaputaina 2012Artigo -
18
-
19
NAD+ Intermediates: The Biology and Therapeutic Potential of NMN and NR mā Jun Yoshino, Joseph A. Baur, Shin‐ichiro Imai
I whakaputaina 2017Revisão -
20
Ngā utauta rapu:
Ngā marau whai pānga
Biology
Biochemistry
Enzyme
NAD+ kinase
Medicine
Internal medicine
Endocrinology
Cell biology
Chemistry
Gene
Nicotinamide adenine dinucleotide
Nicotinamide phosphoribosyltransferase
Nicotinamide mononucleotide
Nicotinamide
Genetics
Downregulation and upregulation
Sirtuin 1
Insulin
Longevity
Insulin resistance
Metabolism
Neuroscience
Adipose tissue
Sirtuin
Receptor
Transcription factor
Acetylation
Apoptosis
Biosynthesis
Diabetes mellitus